Trump Admin Advances Plan for Peptide Drugs Favored by RFK Jr.
U.S. health officials plan to allow specialty pharmacies to produce certain peptides, a largely unregulated class of injections popular with Health Secretary Robert F. Kennedy.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
The odds
Each tick is a source publishing on this story
Price data
| Time | Chance of yes |
|---|---|
| now | 14% |
| 14 Oct, 20:33 UTC | 14% |
The story so far
2 publishers have covered this in 2 articles since 15 Oct 2026. MedPageToday.com - medical news for physicians published first, on 15 October at 20:15 UTC; STAT followed 31 min later. The most recent article, from STAT, appeared on 15 October at 20:46 UTC.
Outlets reporting it: MedPageToday.com - medical news for physicians, STAT.
One prediction market prices this story:
- Peptide — the market puts it at 14%, closing 1 Nov 2026. The outcome is Yes if Donald Trump states the word Peptide, or a plural or possessive form of it, between October 1, 2026 at 10:00am ET and November 1, 2026 at 12:00am ET. Otherwise, the outcome is No. Readers often mistake the linked news story as sufficient evidence, but only a direct statement by Trump during the specified window counts.
Odds are the market's probability that the outcome happens, updated every few minutes. They are information about what traders expect, not a forecast we make and not investment advice.
Sources
Every article we clustered into this story. Headlines link to the publisher.
Markets on this story
- Kalshi Peptide 14%
Does the market have this right?
Wrong market?
Have your say
Your call. How does this end?
Free, no money involved. Calls are scored against the market's price when you make them, so backing an underdog that wins scores most. Leaderboard · Your calls
Email me when the odds move
In this story
- Donald Trump
- Robert F. Kennedy